ERS-PERK Signaling Pathway-Mediated Nrf2/ARE-HO-1 Axis: A Novel Therapeutic Target for Attenuating Myocardial Ischemia and Reperfusion Injury

Jichun Wang,Xiaorong Hu,Hong Jiang

DOI: https://doi.org/10.1016/j.ijcard.2015.11.033

IF: 4.039

2016-01-01

International Journal of Cardiology

Abstract:Myocardial reperfusion therapy is the most important therapeutic strategy for myocardial infarction (MI) by reversing myocardial ischemia and reducing the infarct size. However, the subsequent ischemia and reperfusion (I/R) injury may dramatically alleviate the therapeutic benefits [ [1] Wang J. Hu X. Jiang H. Nrf-2-HO-1-HMGB1 axis: an important therapeutic approach for protection against myocardial ischemia and reperfusion injury. Int J Cardiol. 2014; 172: 223-224 Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar ]. Hence, protecting against myocardial I/R injury may become a novel therapeutic target.